National Institute of
This page is historical material reflecting the Feedback Loop Blog as it existed on
January 10, 2019. This page is no longer updated and links to external websites
and some internal pages may not work.
January 10, 2019
Archived: Supplements for MIRAs: Clarifying the Policy
UPDATE: Consult the MIRA webpage or your program officer for the current notices of funding opportunities.
Since supplemental grant funding comes in a variety of flavors, with different purposes, it’s not surprising that there’s confusion about which kinds of supplements MIRA grantees may apply for and which they may not. Here’s a quick run-down.
Type of Supplement |
Links to NIH Guide |
Comments |
|---|---|---|
| Revisions (Formerly known as Competitive Supplements) | PAR-17-190 For Early Stage Investigator MIRA PAR-17-094 For Established Investigator MIRA |
Revisions are not an allowed application type in the R35 FOAs except to address special research priorities, e.g., COVID-19. |
| Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Announcement under which administrative supplement requests must be made) | PA-18-591 | Unless otherwise noted NIGMS will only accept administrative supplement requests to fund equipment or to address special research priorities, e.g., Alzheimer’s research. (See below.) |
| Equipment supplements | NOT-GM-19-013 | Eligible to apply |
| Administrative Supplements to Address Special Research Priorities, e.g., Alzheimer’s | NOT-AG-18-039 | Supplement must be for work that falls outside the NIGMS mission and therefore, if successful, would not in the future be funded by NIGMS. This type of supplement generally allows MIRA grantees to explore possible applications of their research to clinical or other areas not funded by NIGMS. |
| Diversity supplements | PA-18-906 | Eligible to apply |
| Re-entry supplements | PA-18-592 | Eligible to apply |
We strongly encourage you to contact your program director before applying for any supplement.
About the Author
